LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 29.19 27.76 1275 1863 0.6843 0.8788
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 29.19 27.76 1297 1863 0.6961 0.8841
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 29.19 27.76 112 1863 0.0601 0.2584
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 29.19 27.76 1682 1863 0.9028 0.9666
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 30.90 27.76 39 2032 0.0192 0.0564
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 30.90 27.76 1393 2032 0.6854 0.8817
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 30.90 27.76 1227 2032 0.6037 0.8435
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 30.90 27.76 1251 2032 0.6155 0.8493
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 30.90 27.76 136 2032 0.0669 0.2925
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 30.90 27.76 1722 2032 0.8473 0.9472
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 32.60 27.76 38 2235 0.0170 0.0508
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 32.60 27.76 1316 2235 0.5886 0.8394
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 32.60 27.76 1304 2235 0.5832 0.8367
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 32.60 27.76 1327 2235 0.5935 0.8418
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 32.60 27.76 164 2235 0.0734 0.3239
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 32.60 27.76 1836 2235 0.8212 0.9387
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 34.30 27.76 56 2449 0.0229 0.1147
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 34.30 27.76 1477 2449 0.6029 0.8494
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 34.30 27.76 1348 2449 0.5503 0.8234
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 34.30 27.76 1370 2449 0.5592 0.8280
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 34.30 27.76 163 2449 0.0665 0.3151
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 34.30 27.76 1874 2449 0.7650 0.9188
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 36.01 27.76 71 2662 0.0267 0.1533
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 36.01 27.76 1579 2662 0.5930 0.8474
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 36.01 27.76 1397 2662 0.5246 0.8133
MN20160318_Q01
H05